Topic: healthcare

Employers Remain Reluctant to Expand Coverage for GLP-1 Obesity Drugs Despite Rising Demand

07/08/2026, 06:36 AM business review healthcare

Despite the introduction of new GLP-1 drugs and Medicare coverage for obesity, employer coverage for these medications remains stagnant, primarily due to high costs. This trend could impact the market for GLP-1 drugs and the overall healthcare landscape as employers seek alternative ways to support employee health.

Jim Cramer Highlights Buying Opportunities Amid Market Rotation, Focuses on Strong Companies

07/07/2026, 10:36 AM economy review healthcare finance

The recent market downturn, particularly in technology stocks, has prompted a shift towards safer investments, with healthcare and financial sectors showing resilience. Jim Cramer highlights potential buying opportunities in fundamentally strong companies amidst this volatility.

Analysts Jefferies recommend quality, low-stress stocks for summer amid AI investment concerns

07/07/2026, 09:36 AM investing recommendation Analysts: analysts, Jefferies ai healthcare

Jefferies advises investors to focus on high-quality, low-stress stocks as market volatility increases due to concerns surrounding artificial intelligence investments. This strategy aims to mitigate risks associated with the current AI-driven market momentum.

Analysts Ritholtz Wealth Management highlight Merck (MRK), Archer-Daniels-Midland (ADM), and State Street (STT) as strong stocks in underperforming sectors

07/06/2026, 08:37 AM investing review Analysts: analysts, Ritholtz healthcare consumer

Investors are encouraged to consider stocks in underperforming sectors, as recent analysis highlights potential opportunities in companies like Merck, Archer-Daniels-Midland, and State Street, which are showing strength despite broader market challenges.

Experts Warn Immigration Policy Changes Could Intensify Care Worker Shortage and Increase Costs for Families

07/03/2026, 05:38 AM investing forecast healthcare

Changes in immigration policy are expected to exacerbate the shortage of long-term care workers in the U.S., leading to increased costs for families seeking care for elderly relatives or those with disabilities. This situation poses significant financial challenges for many American families already struggling with healthcare expenses.

Analysts Raymond James add UnitedHealth Group (UNH) and Janus Living (JAN) to top healthcare picks amid sector rally

07/02/2026, 12:36 PM investing recommendation Analysts: analysts, Raymond James healthcare

Raymond James has identified two healthcare stocks, UnitedHealth Group and Janus Living, as top picks due to their strong performance and attractive dividends, reflecting a broader shift in investor interest towards the healthcare sector amidst a challenging tech market.

Analysts Jim Cramer recommends waiting for a pullback before buying Moderna (MRNA) shares as the company unveils a promising cancer pipeline

07/01/2026, 04:36 PM business recommendation Analysts: analysts healthcare

Moderna is gaining renewed investor interest as it expands its pipeline beyond Covid-19 vaccines, with promising developments in cancer therapies and other vaccine programs. This shift could signal a potential turnaround for the company after a period of uncertainty.

Walmart and CVS Health Enhance Support for Seniors Navigating New Medicare Coverage for Obesity Drugs

07/01/2026, 12:36 PM business announcement healthcare

Medicare's new coverage for obesity drugs marks a significant policy shift that could improve access for millions of seniors, with Walmart and CVS Health stepping in to provide essential support and education to navigate this change.

Anthropic Initiates AI Drug Discovery Program Targeting Neglected Diseases

06/30/2026, 01:36 PM economy announcement ai healthcare

Anthropic is launching an internal drug discovery program aimed at developing AI tools for the pharmaceutical industry, particularly targeting neglected diseases. This move highlights the growing interest of tech companies in the healthcare sector and could position Anthropic as a key player in AI-driven drug development.

Medicare Introduces Coverage for Obesity Drugs, Expanding Access for Millions of Older Americans

06/30/2026, 02:36 AM business announcement healthcare

Medicare's new coverage for obesity drugs marks a significant shift in healthcare access for older Americans, potentially benefiting millions who previously could not afford these medications. This change could greatly impact companies like Novo Nordisk and Eli Lilly as they tap into a new patient demographic.